Companies: 10,795·Total market cap: $144.5T
Myriad Genetics, Inc.

Myriad Genetics, Inc.

MYGNNASDAQHealthcare● Active
$4.39
$-0.18(-3.94%)
Market Cap$414627598
P/E Ratio
52W High$8.59
52W Low$3.53
Overview

Myriad Genetics, Inc.(MYGN)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · MYGN · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.82B$0.84B$0.75B$0.68B$0.69B
Cost of Revenue$0.25B$0.25B$0.24B$0.20B$0.20B
Gross Profit$0.58B$0.59B$0.52B$0.48B$0.49B
Gross Margin %(computed)69.93%69.89%68.64%70.22%71.39%
Operating Expenses
R&D Expenses$0.11B$0.11B$0.09B$0.09B$0.08B
G&A Expenses$0.26B$0.28B$0.28B$0.25B$0.54B
Total Operating Expenses$0.64B$0.71B$0.77B$0.62B$0.68B
Operating Income($0.07B)($0.12B)($0.26B)($0.14B)($0.19B)
Operating Margin %(computed)-8.22%-14.74%-34.17%-20.73%-27.58%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.01B$0.00B$0.00B$0.00B$0.01B
Income Before Tax($0.40B)($0.12B)($0.26B)($0.14B)($0.06B)
Income Tax Expense($0.03B)$0.00B$0.00B($0.03B)($0.03B)
Net Income($0.37B)($0.13B)($0.26B)($0.11B)($0.03B)
Net Margin %(computed)-44.38%-15.20%-34.96%-16.51%-3.94%
Per Share & EBITDA
EPS (Basic)$-3.96$-1.41$-3.18$-1.39$-0.35
Wtd Avg Shares0.09B0.09B0.08B0.08B0.08B
EBITDA($0.33B)($0.06B)($0.20B)($0.08B)$0.01B
EBITDA Margin %(computed)-40.13%-7.10%-26.21%-12.49%1.78%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Myriad Genetics, Inc.

关于Myriad Genetics, Inc.(MYGN)损益表

Myriad Genetics, Inc.(MYGN)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,MYGN实现营收$0.82B,毛利润$0.58B(毛利率69.93%),净利润($0.37B)(净利率-44.38%)。

常见问题

MYGN · 4 问

Myriad Genetics, Inc.(MYGN)2025财年营收为$0.82B,同比down1.6%。

MYGN revenueMYGN salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08